Standard BioTools Inc LAB

fldm receives Add'l $22 M contract for covid testing expans.

[Humanist]

Fluidigm receives additional $22M funding for expansion of Covid testing capacity


Sep. 29, 2020 10:07 AM ET|About: Fluidigm Corporation (FLDM)|By: Manshi Mamtora, CFA, SA News Editor 

On September 28, Fluidigm (FLDM +3.0%) signs a definite agreement with National Institute of Health for a program aimed at increasing the number, type, and availability of tests for Covid-19.

The project funding increased ~$22M, to bring the total contract value at $34M.

This will help expand production capacity and throughput capabilities for COVID-19 testing with Fluidigm microfluidics technology.

The project will be funded in whole or in part with Federal funds from the National Institute of Biomedical Imaging and Bioengineering, NIH, Department of Health and Human Services.

p.s. i seem to bethe only one posting here although many people read my post, c'mon guys i aminterested in whatyou have to say/contribute

[personal]

I would have thought the price would have gone up higher along with t the citron report that put a 35 dollar target. Do you know if they have increased production already?

[Humanist]

Hello personal, good to discuss this stock with  someone on the board, thx for responding. i am not aware of the production part of it, but i read somwhere about a month ago or approx 3 wks that they are already funded to develop commericalize the testing kits etc. I agree with you that citron gave $20 gltarget, the stock hsould've popped more. however i think there are other tests on